What amount sold does Polyamyna Nanotech Inc. report in Form D filings?

The latest linked filings report $354K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Polyamyna Nanotech Inc.'s most recent SEC filing?

Polyamyna Nanotech Inc.'s most recent Form D filing was on 2023-09-06.

How many investors does Polyamyna Nanotech Inc. have?

The most recent Form D filing lists 1 investor(s).

What type of securities does Polyamyna Nanotech Inc. offer?

Polyamyna Nanotech Inc.'s SEC Form D filings indicate equity offerings.

Polyamyna Nanotech Inc.

CIK: 0001992526·Other Health Care·ST. JOHN'S, A4·Corporation

Reported Sold

$353,921

Total Filings

Identified Offerings

Last Filed

Sep 6, 2023

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Health Care industry

SEC EDGAR

Offering filing timeline

Sep 6, 2023Form D — New notice

Reported sold: $353,921 · Target: $353,921

Rule 506(b)·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

$1 - $1,000,000

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$353,921

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Ramesh Kumar Mani

Related Person

Appears on 1 filing

Bala Kishan Gorityala

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 6, 2023	New	$353,921	$353,921	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Frequency Exchange Corp.

Other Health Care

Offering target: $297,207

Filed Nov 5, 2026